Results 1 to 10 of about 2,645,583 (208)

Hormonal therapy in uterine sarcomas

Cancer Medicine, 2019
Uterine sarcomas (USs) are a group of rare but aggressive uterine malignancies, accounting for only 1% of the malignant tumors of female reproductive organs. Due to the high rate of recurrence and metastasis, the prognosis of USs is poor.
Yuqin Zang, Mengting Dong, Kai Zhang, Chao Gao, Fei Guo, Yingmei Wang, Fengxia Xue   +6 more
doaj   +3 more sources

SURVIVAL OF PROSTATE CANCER PATIENTS WITH COMBINATION HORMONAL-RADIOTHERAPY BETTER THAN HORMONAL THERAPY [PDF]

Jurnal Urologi Indonesia, 2020
Objective: This study aims to determine the survival of prostate cancer (PCa) patients who did not undergo radical prostatectomy, but received hormonal therapy or a combination of radiotherapy and hormonal therapy.
Exsa Hadibrata, Untung Tranggono
doaj   +2 more sources

Hormonal therapies and venous thrombosis: Considerations for prevention and management

Research and Practice in Thrombosis and Haemostasis, 2022
Background Venous thromboses are well‐established complications of hormonal therapy. Thrombosis risk is seen with both hormonal contraceptive agents and with hormone replacement therapy for menopause and gender transition.
Corinne LaVasseur, Suvi Neukam, Thomas Kartika, Bethany Samuelson Bannow, Joseph Shatzel, Thomas G. DeLoughery   +5 more
doaj   +2 more sources

Estetrol: a new estrogen component in combined oral contraceptives: A review [PDF]

Гинекология, 2023
Estetrol (E4) is a steroid hormone found in the urine of pregnant women in 1965. E4 is produced only during pregnancy and enters the maternal bloodstream through the placenta.
Aida U. Hamadyanova, Afzal H. Tuhtaboev, Venera A. Shafieva, Elena A. Kolodyazhnaya, Julia R. Mansurova, Aliya A. Muratova, Arina A. Andreeva, Julia A. Muzafarova   +7 more
doaj   +1 more source

Assessment of compliance with hormonal therapy in early breast cancer patients with positive hormone receptor phenotype: A single institution study

Breast, 2022
Background: Adherence to long-term adjuvant hormonal therapy in hormonal receptors (HR)-positive breast cancer is really challenging and can affect the survival outcome.
Shereef Ahmed Elsamany, Hossam Alghanmi, Abdelrahman Albaradei, Rasha Abdelhamid, Eman Madi, Amira Ramzan   +5 more
doaj   +1 more source

Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data

BMC Cancer, 2022
Background This study assesses the use of hormonal therapy to treat high-risk localized prostate cancer (HRLPCa) cases diagnosed between 2005 and 2015. Methods All N0-XM0 with ≥T3a, or PCa cases with poorly differentiated feature (equivalent to Gleason ...
Semaw Ferede Abera, Ahmed Bedir, André Glowka, Dirk Vordermark, Daniel Medenwald   +4 more
doaj   +1 more source

Effects of intermittent very‐low calorie diet on glycemic control and cardiovascular risk factors in obese patients with type 2 diabetes mellitus: A randomized controlled trial

Journal of Diabetes Investigation, 2022
Aims/Introduction Very few studies assess the effectiveness of different protocols of intermittent very‐low calorie diet (VLCD) in patients with diabetes.
Mongkontida Umphonsathien, Peedaporn Rattanasian, Siriporn Lokattachariya, Wanlapa Suansawang, Kunwadee Boonyasuppayakorn, Weerapan Khovidhunkit   +5 more
doaj   +1 more source

Factors affecting Adherence to Adjuvant Hormonal Therapy among Women with Breast Cancer [PDF]

Egyptian Journal of Health Care, 2022
Background: Breast cancer is the most common cancer in women worldwide. Also, is the leading cause of death in women, Adjuvant endocrine therapy is a treatment that significantly reduces recurrence and mortality in women with hormone receptor-positive ...
Diaa Eldin Moussa Sherif, Yosreah Mohamed Mohamed, Manal Salah Hassan, Amany Refaat Elmaadawy   +3 more
doaj   +1 more source

Diagnostics and management of vulvovaginal atrophy according to the international guidelines

Фундаментальная и клиническая медицина, 2022
Vulvovaginal atrophy is one of the genitourinary symptoms caused by estrogen deficiency which leads to the development of immature vaginal epithelium, glycogen deficiency, reduction or even elimination of lactobacilli, and secondary genitourinary tract ...
K. V. Dmitrienko, S. D. Yavorskaya, G. V. Nemtseva   +2 more
doaj   +1 more source

Sequential treatment with transurethral resection and hormonal therapy for bladder endometriosis of vesicoureteric junction [PDF]

Journal of Medicine and Life Science, 2022
Objective: To estimate the efficacy of sequential treatment of bladder endometriosis (BE) of the vesicoureteric junction using transurethral resection (TUR) and hormonal therapy. Design: Case report. Setting: Private multispecialty hospital.
Abdulelah lAdimi, Nabil AlOdaini, Atef M. M. Darwish   +2 more
doaj   +1 more source